Skip to main content

Supermarket execs to lead chain drug group


Two big grocery chain executives will be overseeing the board of the National Association of Chain Drug Stores.

NACDSannounced during its Annual Meetingthe election of new officers, four new executive committee members and five new board of directors member for the coming year.

Randy Edeker, chairman, president and chief executive officer of Hy-Vee will serve as the new NACDS chairman of the board of directors. Edeker succeeds John Standley, chairman and chief executive officer of Rite Aid.

In addition, Martin Otto, chief merchant and CFO of H-E-B, was elected vice chairman, and J.K. Symancyk, president of Meijer, was elected treasurer. Each officer will serve a one-year term.

“I congratulate Randy Edeker on his election as NACDS chairman of the Board of Directors,” said NACDS president and CEO Steven Anderson, IOM, CAE. “During his service on the Executive Committee, Randy’s leadership helped drive NACDS’ activities on key industry issues and policies. His extraordinary leadership at Hy-Vee has driven continued success and further illustrates his commitment to the industry. We look forward to working with him in his new role with NACDS in the coming year.”

The NACDS Board also elected the following new executive committee members: Labeed Diab, president of health and wellness with Walmart; Alex Gourlay, president of Walgreens; Martin Otto, chief merchant and CFO of H-E-B; and J.K. Symancyk, president of Meijer.

The five new board of directors members, who were elected to serve three-year terms, include: Richard Ashworth, president, pharmacy and retail operations with Walgreens ; Helena Foulkes, president, CVS/pharmacy and EVP, CVS Caremark, with CVS Health; Jon Giacomin, CEO, pharmaceutical segment with Medicine Shoppe International; Alex Gourlay, president of Walgreen Co.; and David Neu, president, Good Neighbor Pharmacy.
This ad will auto-close in 10 seconds